35.87 +0.40 (1.13%)
ENDP
| Trade ENDP now with |
|
Stock Details
Last Trade:35.87 Change:+0.40 (1.13%) Prev Close:35.47 Open: 35.44 Days Range:35.09 – 36.82 52 Week Range: 26.02 - 44.53 Volume:2832398 P/E: 17.76EPS:2.02
View AllRecent Alerts 02/09/12
Recent Alert on 02/06/12 at 8:22am
Needham & Company Maintains a 'Strong Buy' on Mylan (MYL)l Mid-May Is D-Day for Generic Lidoderm, Not July
Needham & Company Maintains a 'Strong Buy' on Mylan (MYL)l Mid-May Is D-Day for Generic Lidoderm, Not July
Needham & Company maintains a 'Strong Buy' on Mylan (NASDAQ: MYL) price target of $29.00. Analyst, Elliot Wilbur, says, "In the fast and furious world of paragraph IV patent challenges, he who files first usually steals the show. However, given... Read More
Recent Alert on 01/30/12 at 7:54am
Jefferies Cuts Numbers on Endo Pharmaceuticals (ENDP); Lots of Moving Parts But Expect Q1 Weakness
Jefferies Cuts Numbers on Endo Pharmaceuticals (ENDP); Lots of Moving Parts But Expect Q1 Weakness
Recent Alert on 01/12/12 at 1:55pm
UBS on U.S. Pharma – Large Cap and Specialty: 4Q11 Preview: Things Still Look Interesting
UBS on U.S. Pharma – Large Cap and Specialty: 4Q11 Preview: Things Still Look Interesting
Recent Alert on 01/09/12 at 8:34am
Endo Pharma (ENDP) Sees Supply Constraint on OPANA ER w/ Recent Facility Shutdown
Endo Pharma (ENDP) Sees Supply Constraint on OPANA ER w/ Recent Facility Shutdown
View AllRecent Press Releases
Press Release on 02/06/12 at 9:00am
2012 Economic Outlook - Report Highlights Bed Bath & Beyond Inc. and Endo Pharmaceuticals
2012 Economic Outlook - Report Highlights Bed Bath & Beyond Inc. and Endo Pharmaceuticals
Press Release on 02/06/12 at 9:00am
A Forward Look, the Year Ahead - Featured Research on Sanofi SA (ADR) and Endo Pharmaceuticals
A Forward Look, the Year Ahead - Featured Research on Sanofi SA (ADR) and Endo Pharmaceuticals
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 02/03/12 at 1:09pm
BioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target
BioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target
Blog Posts on 01/17/12 at 4:49am
Questor Pharmaceuticals: Quickly Building A Multi-Billion Dollar Business
Questor Pharmaceuticals: Quickly Building A Multi-Billion Dollar Business